Polynovo Ltd Net Assets
Polynovo Ltd net assets. Based on the latest financial reports, Polynovo Ltd (PNV) has net assets worth AU$83.14 Million AUD (≈ $58.83 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$123.37 Million ≈ $87.29 Million USD) and total liabilities (AU$40.23 Million ≈ $28.46 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Polynovo Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$83.14 Million |
| % of Total Assets | 67.39% |
| Annual Growth Rate | 10.2% |
| 5-Year Change | 272.5% |
| 10-Year Change | 450.98% |
| Growth Volatility | 74.24 |
Net Assets of Polynovo Ltd (1999–2025)
Net assets of Polynovo Ltd from 1999 to 2025. This chart illustrates how Polynovo Ltd's net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Polynovo Ltd to measure how much of total assets are equity-financed.
Annual Net Assets for Polynovo Ltd (1999–2025)
The table below shows the annual net assets of Polynovo Ltd from 1999 to 2025. For live market cap and overall valuation, see Polynovo Ltd (PNV) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$83.26 Million ≈ $58.91 Million |
+15.44% |
| 2024-06-30 | AU$72.12 Million ≈ $51.03 Million |
+10.31% |
| 2023-06-30 | AU$65.38 Million ≈ $46.26 Million |
+269.08% |
| 2022-06-30 | AU$17.72 Million ≈ $12.53 Million |
-20.75% |
| 2021-06-30 | AU$22.35 Million ≈ $15.82 Million |
-6.13% |
| 2020-06-30 | AU$23.81 Million ≈ $16.85 Million |
-8.76% |
| 2019-06-30 | AU$26.10 Million ≈ $18.47 Million |
-8.29% |
| 2018-06-30 | AU$28.46 Million ≈ $20.14 Million |
+163.20% |
| 2017-06-30 | AU$10.81 Million ≈ $7.65 Million |
-28.45% |
| 2016-06-30 | AU$15.11 Million ≈ $10.69 Million |
+104.40% |
| 2015-06-30 | AU$7.39 Million ≈ $5.23 Million |
-14.71% |
| 2014-06-30 | AU$8.67 Million ≈ $6.13 Million |
+10.87% |
| 2013-06-30 | AU$7.82 Million ≈ $5.53 Million |
-2.14% |
| 2012-06-30 | AU$7.99 Million ≈ $5.65 Million |
-24.92% |
| 2011-06-30 | AU$10.64 Million ≈ $7.53 Million |
-22.57% |
| 2010-06-30 | AU$13.74 Million ≈ $9.72 Million |
-13.15% |
| 2009-06-30 | AU$15.82 Million ≈ $11.20 Million |
-3.88% |
| 2008-06-30 | AU$16.46 Million ≈ $11.65 Million |
-20.81% |
| 2007-06-30 | AU$20.79 Million ≈ $14.71 Million |
-8.68% |
| 2006-06-30 | AU$22.76 Million ≈ $16.11 Million |
+31.73% |
| 2005-06-30 | AU$17.28 Million ≈ $12.23 Million |
+3.58% |
| 2004-06-30 | AU$16.68 Million ≈ $11.81 Million |
+166.47% |
| 2003-06-30 | AU$6.26 Million ≈ $4.43 Million |
-48.46% |
| 2002-06-30 | AU$12.15 Million ≈ $8.60 Million |
+89.58% |
| 2001-06-30 | AU$6.41 Million ≈ $4.53 Million |
-44.07% |
| 2000-06-30 | AU$11.46 Million ≈ $8.11 Million |
+72.17% |
| 1999-06-30 | AU$6.66 Million ≈ $4.71 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Polynovo Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10126735800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Polynovo Ltd Net Assets Breakdown (June 2025)
Polynovo Ltd net assets breakdown by equity component as of June 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$191.76 Million | 230.31% |
| Other Comprehensive Income | AU$-5.59 Million | -6.72% |
| Total Equity | AU$83.26 Million | 100.00% |
Polynovo Ltd Competitors by Market Cap
The table below lists competitors of Polynovo Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RPG Life Sciences Limited
NSE:RPGLIFE
|
$452.45 Million |
|
Jiangxi Huawu Brake Co Ltd
SHE:300095
|
$452.50 Million |
|
MiCo Ltd
KQ:059090
|
$452.50 Million |
|
QUADIENT SA ADR1/15/EO 1
F:NEQ0
|
$452.52 Million |
|
Everbright Jiabao Co Ltd
SHG:600622
|
$452.07 Million |
|
Kneat.com Inc
TO:KSI
|
$452.01 Million |
|
Puradelta Lestari PT
JK:DMAS
|
$451.87 Million |
|
Shenzhen Silver Basis Technology Co Ltd
SHE:002786
|
$451.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Polynovo Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 72,124,000 to 83,262,000, a change of 11,138,000 (15.4%).
- Net income of 13,214,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 2,233,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$13.21 Million | +15.87% |
| Other Comprehensive Income | AU$-2.23 Million | -2.68% |
| Other Changes | AU$157.00K | +0.19% |
| Total Change | AU$- | 15.44% |
Book Value vs Market Value Analysis
This analysis compares Polynovo Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.77x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.21x to 7.77x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-06-30 | AU$4.46 | AU$0.93 | x |
| 2000-06-30 | AU$0.62 | AU$0.93 | x |
| 2001-06-30 | AU$0.32 | AU$0.93 | x |
| 2002-06-30 | AU$0.57 | AU$0.93 | x |
| 2003-06-30 | AU$0.27 | AU$0.93 | x |
| 2004-06-30 | AU$0.08 | AU$0.93 | x |
| 2005-06-30 | AU$0.08 | AU$0.93 | x |
| 2006-06-30 | AU$0.09 | AU$0.93 | x |
| 2007-06-30 | AU$0.07 | AU$0.93 | x |
| 2008-06-30 | AU$0.05 | AU$0.93 | x |
| 2009-06-30 | AU$0.05 | AU$0.93 | x |
| 2010-06-30 | AU$0.04 | AU$0.93 | x |
| 2011-06-30 | AU$0.03 | AU$0.93 | x |
| 2012-06-30 | AU$0.02 | AU$0.93 | x |
| 2013-06-30 | AU$0.02 | AU$0.93 | x |
| 2014-06-30 | AU$0.02 | AU$0.93 | x |
| 2015-06-30 | AU$0.02 | AU$0.93 | x |
| 2016-06-30 | AU$0.03 | AU$0.93 | x |
| 2017-06-30 | AU$0.02 | AU$0.93 | x |
| 2018-06-30 | AU$0.05 | AU$0.93 | x |
| 2019-06-30 | AU$0.04 | AU$0.93 | x |
| 2020-06-30 | AU$0.04 | AU$0.93 | x |
| 2021-06-30 | AU$0.03 | AU$0.93 | x |
| 2022-06-30 | AU$0.03 | AU$0.93 | x |
| 2023-06-30 | AU$0.10 | AU$0.93 | x |
| 2024-06-30 | AU$0.10 | AU$0.93 | x |
| 2025-06-30 | AU$0.12 | AU$0.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Polynovo Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.87%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.38%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 1.53x
- Recent ROE (15.87%) is above the historical average (-32.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | -24.58% | 0.00% | 0.00x | 1.06x | AU$-2.30 Million |
| 2000 | -31.10% | -693.19% | 0.04x | 1.04x | AU$-4.71 Million |
| 2001 | -79.13% | -1043.42% | 0.07x | 1.13x | AU$-5.71 Million |
| 2002 | -47.17% | -1528.27% | 0.03x | 1.04x | AU$-6.95 Million |
| 2003 | -136.87% | -1464.96% | 0.08x | 1.19x | AU$-9.20 Million |
| 2004 | -57.20% | -1141626.79% | 0.00x | 1.12x | AU$-11.21 Million |
| 2005 | -62.29% | 0.00% | 0.00x | 1.08x | AU$-12.49 Million |
| 2006 | -49.61% | -6344943.82% | 0.00x | 1.10x | AU$-13.57 Million |
| 2007 | -64.49% | -307077.42% | 0.00x | 1.06x | AU$-15.49 Million |
| 2008 | -26.98% | 0.00% | 0.00x | 1.04x | AU$-6.09 Million |
| 2009 | -12.54% | 0.00% | 0.00x | 1.19x | AU$-3.29 Million |
| 2010 | -13.54% | -1527.36% | 0.01x | 1.09x | AU$-3.24 Million |
| 2011 | -27.32% | -751.41% | 0.03x | 1.10x | AU$-3.98 Million |
| 2012 | -33.62% | -1116.97% | 0.03x | 1.11x | AU$-3.50 Million |
| 2013 | -18.98% | -1325.46% | 0.01x | 1.10x | AU$-2.28 Million |
| 2014 | -33.68% | -4877.40% | 0.01x | 1.08x | AU$-3.81 Million |
| 2015 | -17.23% | -5828.37% | 0.00x | 1.08x | AU$-2.06 Million |
| 2016 | -20.26% | -93.44% | 0.20x | 1.06x | AU$-4.57 Million |
| 2017 | -46.30% | -138.29% | 0.30x | 1.11x | AU$-6.09 Million |
| 2018 | -20.99% | -91.15% | 0.22x | 1.05x | AU$-8.82 Million |
| 2019 | -12.22% | -22.71% | 0.50x | 1.08x | AU$-5.80 Million |
| 2020 | -17.61% | -18.93% | 0.59x | 1.59x | AU$-6.58 Million |
| 2021 | -20.60% | -15.79% | 0.76x | 1.72x | AU$-6.84 Million |
| 2022 | -6.73% | -2.88% | 1.18x | 1.97x | AU$-2.96 Million |
| 2023 | -7.53% | -7.55% | 0.70x | 1.42x | AU$-11.46 Million |
| 2024 | 7.29% | 5.10% | 0.95x | 1.51x | AU$-1.95 Million |
| 2025 | 15.87% | 10.38% | 1.00x | 1.53x | AU$4.89 Million |
Industry Comparison
This section compares Polynovo Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $86,522,583
- Average return on equity (ROE) among peers: -38.54%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Polynovo Ltd (PNV) | AU$83.14 Million | -24.58% | 0.48x | $452.15 Million |
| 4DMEDICAL Ltd (4DX) | $83.36 Million | -25.70% | 0.11x | $978.43 Million |
| Adherium Ltd (ADR) | $5.54 Million | -181.40% | 0.54x | $2.60 Million |
| Aroa Biosurgery Ltd (ARX) | $15.23 Million | 0.00% | 0.29x | $120.22 Million |
| Atomo Diagnostics Ltd (AT1) | $-4.89 Million | 0.00% | 0.00x | $8.94 Million |
| Avita Medical Inc (AVH) | $12.96 Million | -89.99% | 0.20x | $188.51 Million |
| Anteris Technologies Global Corp (AVR) | $1.24 Million | -94.76% | 0.13x | $581.11 Million |
| Control Bionics Ltd (CBL) | $5.05 Million | -38.22% | 0.07x | $18.83 Million |
| Cardiex Ltd (CDX) | $792.00K | 0.00% | 0.97x | $13.23 Million |
| Compumedics Ltd (CMP) | $20.05 Million | 6.51% | 0.46x | $33.22 Million |
| Cochlear Ltd (COH) | $725.90 Million | 38.12% | 0.90x | $6.56 Billion |
About Polynovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more